Trials / Completed
CompletedNCT00591227
Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
Management of Hyperglycemia in the Emergency Room: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 176 (actual)
- Sponsor
- Rush University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine two questions: 1. Whether insulin treatment of high blood sugar in patients with diabetes while they are in the emergency room will improve how quickly they recover from illness if they need to be hospitalized. 2. Whether immediately beginning long lasting insulin detemir in patients with diabetes when they are admitted to hospital from the emergency room will improve how quickly they recover from the illness which necessitated hospitalization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | insulin aspart | insulin aspart: insulin aspart will be given every 2 hours dosed from 0.05 to 0.15 units per kg weight to patients with a prior history of diabetes if blood glucose is more than 200 mg/dl in the ER. If subjects are admitted to hospital then they will receive insulin detemir 0.3 units/kg daily and insulin aspart 0.1 units/kg per meal if they are eating. |
| DRUG | insulin detemir | insulin detemir: insulin aspart will be given every 2 hours dosed from 0.05 to 0.15 units per kg weight to patients with a prior history of diabetes if blood glucose is more than 200 mg/dl in the ER. If subjects are admitted to hospital then they will receive insulin detemir 0.3 units/kg daily and insulin aspart 0.1 units/kg per meal if they are eating.If subjects are admitted to hospital then they will receive insulin detemir 0.3 units/kg daily and insulin aspart 0.1 units/kg per meal if they are eating. |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-01-11
- Last updated
- 2022-02-07
- Results posted
- 2011-05-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00591227. Inclusion in this directory is not an endorsement.